BETA-NAPHTHYLAMINE AND BENZIDINE: IDENTIFICATION OF GROUPS AT HIGH RISK OF BLADDER CANCER von Johnson, William M., Parnes, William D.

Volltext

Systolic Time Intervals before and after Maximal Exercise Treadmill Testing for Evaluation of Chest Pain von Gillilan, Ronald E., Parnes, William D., Mondell, Brian E., Bouchard, Richard J., Warbasse, J. Richard

Volltext

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial von Madan, Ravi A, MD, Mohebtash, Mahsa, MD, Arlen, Philip M, MD, Vergati, Matteo, MD, Rauckhorst, Myrna, RN, Steinberg, Seth M, PhD, Tsang, Kwong Y, PhD, Poole, Diane J, Parnes, Howard L, MD, Wright, John J, MD PhD, Dahut, William L, MD, Schlom, Jeffrey, PhD, Gulley, James L, Dr

Volltext

Industrial Experience With 3,3'-Dichlorobenzidine: An Epidemiological Study of a Chemical Manufacturing Plant von Gerarde, H. W., Gerarde, Dorothy F., Hricko, Andrea H., Parnes, William D.

Volltext

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors von Apolo, Andrea B, Nadal, Rosa, Girardi, Daniel M, Niglio, Scot A, Ley, Lisa, Cordes, Lisa M, Steinberg, Seth M, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N, Costello, Rene, Trepel, Jane B, Lee, Min-Jung, Merino, Maria J, Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D, Gulley, James L, Agarwal, Piyush K, Valera, Vladimir, Chalfin, Heather J, Jones, Jennifer, Streicher, Howard, Wright, John J, Ning, Yangmin M, Parnes, Howard L, Dahut, William L, Bottaro, Donald P, Lara, Jr, Primo N, Saraiya, Biren, Pal, Sumanta K, Stein, Mark N, Mortazavi, Amir

Volltext

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial von Apolo, Andrea B, Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N, Cordes, Lisa M, Steinberg, Seth M, Cao, Liang, Parnes, Howard L, Costello, Rene, Merino, Maria J, Folio, Les R, Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V, Yuno, Akira, Dawson, Nancy A, Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M, Sissung, Tristan M, Figg, William D, Agarwal, Piyush K, Wright, John J, Ning, Yangmin M, Gulley, James L, Dahut, William L, Bottaro, Donald P, Trepel, Jane B

Volltext

Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience von Chen, Evan C., Gibson, William, Temoczko, Paula, Connell, Nathan T., Handin, Robert, Parnes, Aric D.

Volltext

Randomized Phase II Trial of Docetaxel Plus Thalidomide in Androgen-Independent Prostate Cancer von DAHUT, William L, GULLEY, James L, PARKER, Catherine E, LINEHAN, W. Marston, FIGG, William D, ARLEN, Philip M, YINONG LIU, FEDENKO, Katherine M, STEINBERG, Seth M, WRIGHT, John J, PARNES, Howard, CHEN, Clara C, JONES, Elizabeth

Volltext

Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer von Ning, Yang-Min, Gulley, James L, Arlen, Philip M, Woo, Sukyung, Steinberg, Seth M, Wright, John J, Parnes, Howard L, Trepel, Jane B, Lee, Min-Jung, Kim, Yeong Sang, Sun, Haihao, Madan, Ravi A, Latham, Lea, Jones, Elizabeth, Chen, Clara C, Figg, William D, Dahut, William L

Volltext

Knowledge of Chosen Family History and Depressive Symptoms in Sexual Minority Women von Gardella, Jamie M., Parnes, McKenna F., Hirst, William, Brown, Adam D.

Volltext

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial von Chau, Cindy H, Price, Douglas K, Till, Cathee, Goodman, Phyllis J, Chen, Xiaohong, Leach, Robin J, Johnson-Pais, Teresa L, Hsing, Ann W, Hoque, Ashraful, Tangen, Catherine M, Chu, Lisa, Parnes, Howard L, Schenk, Jeannette M, Reichardt, Juergen K V, Thompson, Ian M, Figg, William D

Volltext

Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial von PLATZ, Elizabeth A, TILL, Cathee, GOODMAN, Phyllis J, PARNES, Howard L, FIGG, William D, ALBANES, Demetrius, NEUHOUSER, Marian L, KLEIN, Eric A, THOMPSON, Ian M, KRISTAL, Alan R

Volltext

Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Trial von Rauch, Steven D, Halpin, Christopher F, Antonelli, Patrick J, Babu, Seilesh, Carey, John P, Gantz, Bruce J, Goebel, Joel A, Hammerschlag, Paul E, Harris, Jeffrey P, Isaacson, Brandon, Lee, Daniel, Linstrom, Christopher J, Parnes, Lorne S, Shi, Helen, Slattery, William H, Telian, Steven A, Vrabec, Jeffrey T, Reda, Domenic J

Volltext

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy von Girardi, Daniel M, Niglio, Scot A, Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K, Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M, Costello, Rene, Chan, Keith S, Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J, Valera, Vladimir, Figg, William D, Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J, Sharon, Elad, Parnes, Howard L, Ning, Yang-Min, Bottaro, Donald P, Cao, Liang, Trepel, Jane B, Apolo, Andrea B

Volltext

Phase II clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer von Dahut, William L., Madan, Ravi A., Karakunnel, Joyson J., Adelberg, David, Gulley, James L., Turkbey, Ismail B., Chau, Cindy H., Spencer, Shawn D., Mulquin, Marcia, Wright, John, Parnes, Howard L., Steinberg, Seth M., Choyke, Peter L., Figg, William D.

Volltext

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab von Chen, Evan C., Gibson, William J., Temoczko, Paula, Connell, Nathan T., Handin, Robert, Parnes, Aric D.

Volltext

Addressing overdiagnosis and overtreatment in cancer: a prescription for change von Esserman, Laura J, Prof, Thompson, Ian M, Prof, Reid, Brian, Prof, Nelson, Peter, Prof, Ransohoff, David F, Prof, Welch, H Gilbert, Prof, Hwang, Shelley, MD, Berry, Donald A, Prof, Kinzler, Kenneth W, Prof, Black, William C, Prof, Bissell, Mina, Prof, Parnes, Howard, PhD, Srivastava, Sudhir, PhD

Volltext

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers von ANTONARAKIS, Emmanuel S, HEATH, Elisabeth I, BAKER, Sharyn D, PARNES, Howard L, DEWEESE, Theodore L, PARTIN, Alan W, CARDUCCI, Michael A, WALCZAK, Janet R, NELSON, William G, FEDOR, Helen, DE MARZO, Angelo M, ZAHURAK, Marianna L, PIANTADOSI, Steven, DANNENBERG, Andrew J, GURGANUS, Robin T

Volltext

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults with Advanced/Metastatic Urothelial Carcinoma von Apolo, Andrea B, Karzai, Fatima H, Trepel, Jane B, Alarcon, Sylvia, Lee, Sunmin, Lee, Min-Jung, Tomita, Yusuke, Cao, Liang, Yu, Yunkai, Merino, Maria J, Madan, Ravi A, Parnes, Howard L, Steinberg, Seth M, Walter Rodriguez, Beatriz, Seon, Ben K, Gulley, James L, Arlen, Philip M, Dawson, Nancy A, Figg, William D, Dahut, William L

Volltext

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial von Price, Douglas K., Chau, Cindy H., Till, Cathee, Goodman, Phyllis J., Leach, Robin J., Johnson‐Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Parnes, Howard L., Schenk, Jeannette M., Tangen, Catherine M., Thompson, Ian M., Reichardt, Juergen K. V., Figg, William D.

Volltext